CIRCADIAN RHYTHMS OF BASIC FIBROBLAST GROWTH FACTOR (bFGF), EPIDERMAL GROWTH FACTOR (EGF), INSULIN-LIKE GROWTH FACTOR-1 (IGF-1), INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3), CORTISOL, AND MELATONIN IN WOMEN WITH BREAST CANCER

REFERENCES

• Blask D. E. Neuroendocrine Aspects of Circadian Pharmacodynamics. Circadian Cancer Therapy, W. J.M. Hrushesky. CRC Press, Boca Raton, FL 1994; 43–59
   Google Scholar
• Wood P. A., Hrushesky W. J.M. Chronopharmacodynamics of Hematopoietic Growth Factors and Antitumor Cytokines. Circadian Cancer Therapy, W. J.M. Hrushesky. CRC Press, Boca Raton, FL 1994; 185–207
   Google Scholar
• Folkman J. What Is the Evidence that Tumors Are Angiogenesis Dependent?. J. Natl. Cancer Inst. 1990; 82: 4–6
   PubMed Web of Science ®Google Scholar
• Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 1992; 267: 10931–10934
   PubMed Web of Science ®Google Scholar
• Sliutz G., Tempfer C., Obermair A., Dadakm C., Kainz C. Serum Evaluation of Basic FGF in Breast Cancer Patients. Anticancer Res. 1995; 15(6B)2675–2677
   PubMed Web of Science ®Google Scholar
• Kurimoto M., Endo S., Hirashim Y., Nishijima M., Takaku A. Elevated Plasma Basic Fibroblast Growth Factor in Brain Tumor Patients. Neurol. Med. Chir. (Tokyo) 1996; 36(12)865–868
   PubMedGoogle Scholar
• Leunig A., Tauber S., Spaett R., Grevers G., Leunig M. Basic Fibroblast Growth Factor in Serum and Urine of Patients with Head and Neck Cancer. Oncol. Rep. 1998; 5(4)955–958
   PubMed Web of Science ®Google Scholar
• Nguyen M., Watanabe H., Budson A. E., Richie J. P., Hayes D. F., Folkman J. Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients with a Wide Spectrum of Cancers. J. Natl. Cancer Inst. 1994; 86(5)356–360
   PubMed Web of Science ®Google Scholar
• Scheving L. E., Tsai T. H., Scheving L. A., Feures R. J., Kanabrocki E. L. Normal and Abnormal Cell Proliferation in Mice Especially as It Relates to Cancer. Biological Rhythms in Clinical and Laboratory Medicine, Y. Touitou, E. Haus. Springer Verlag, New York 1994; 566–599
   Google Scholar
• Scheving L. E., Feures R. J., Tsai T. H., Scheving L. A. Experimental Background for Cancer Chronotherapy. Circadian Cancer Therapy, W. J.M. Hrushesky. CRC Press, Boca Raton, FL 1994; 19–40
   Google Scholar
• Klevecz R. R., Braly P. S. Circadian and Ultradian Cytokinetics of Human Cancers. Circadian Cancer Therapy, W. J.M. Hrushesky. CRC Press, Boca Raton, FL 1994; 165–187
   Google Scholar
• Voutilainen A. Über die 24-Stunden-Rhythmik der Mitosenfrequenz in malignen Tumoren. Acta Pathol. Microbiol. Scand. 1953; 99(suppl.)1
   Google Scholar
• von Roemeling R. Chronobiology of Endocrine and Endocrine-Responsive Tumors. Biological Rhythms in Clinical and Laboratory Medicine, Y. Touitou, E. Haus. Springer Verlag, New York 1994; 600–610
   Google Scholar
• Redfern P., Lemmer B. Physiology and Pharmacology of Biologic Rhythms. Springer Verlag, Berlin 1997
   Google Scholar
• Touitou Y., Haus E. Biological Rhythms in Clinical and Laboratory Medicine. Springer Verlag, New York 1994; 730
   Google Scholar
• VanCauter E., Turek F. W. Endocrine and Other Biologic Rhythms. Endocrinology, L. DeGroot. 3rd Ed., W.B. Saunders, Philadelphia 1995; 3: 2487–2548
   Google Scholar
• Mormont M. C., Levi F. Circadian System Alterations During Cancer Processes. A Review. Int. J. Cancer 1997; 70: 241–247
   PubMed Web of Science ®Google Scholar
• Touitou Y., Levi F., Bogdan A., Benavides M., Baillent F., Misset T. L. Rhythm Alterations in Patients with Metastatic Breast Cancer and Poor Prognostic Factors. J. Cancer Res. Clin. Oncol. 1995; 121: 181–188
   PubMed Web of Science ®Google Scholar
• Lipman T., Halberg F., Ellis J., Bittner J. J. Pituitary Growth Hormone and Mitoses in Immature Mouse Liver. Endocrinology 1958; 62: 361–364
   PubMed Web of Science ®Google Scholar
• Haus E. Periodicity in Response and Susceptibility to Environmental Agents. Ann. NY Acad. Sci. 1964; 117: 281–291
   PubMed Web of Science ®Google Scholar
• Halberg F., Haus E., Cardoso S. S., Scheving L. E., Kuhl J. F.W., Shiotsuka R., Rosene G., Pauly J. E., Runge W., Spalding J. F., Lee J. K., Good R. A. Toward a Chronotherapy of Neoplasia: Tolerance of Treatment Depends upon Host Rhythms. Experientia 1973; 29: 909–934
   PubMedGoogle Scholar
• Sanchez de la Pena S., Halberg F., Ungar F., Haus E., Lakatua D., Scheving L. E., Sanchez E., Vecsei P. Circadian Pineal Modulation of Pituitary Effect on Murine Corticosterone In Vitro. Brain Res. Bull. (Ankho Int.) 1983; 10: 559–565
   PubMed Web of Science ®Google Scholar
• Lakatua D. J., Labrosse K., Haus E., Sackett L., Halberg F. Circadian Periodicity in Sex Hormone Receptor Activity in Balb/c Mice. Chronobiologia 1979; 6: 267
   Google Scholar
• Lakatua D. J., Haus E., Labrosse K., Veit C., Sackett-Lundeen L. Circadian Rhythm in Mammary Cytoplasmic Estrogen Receptor Content of Balb/c female Mice With and Without Pituitary Isografts. Chronobiol. Int. 1986; 3: 213–219
   PubMed Web of Science ®Google Scholar
• Dirix L. Y., Vermenleu P. B., Pawinsky A., Prové A., Benoy I., DePooter C., Martin M., Van Oosterom A. T. Elevated Levels of the Angiogenic Cytokines Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Sera of Cancer Patients. Br. J. Cancer 1997; 76(2)238–243
   PubMed Web of Science ®Google Scholar
• Folkman J. The Influence of Angiogenesis Research on Management of Patients with Breast Cancer. Breast Cancer Res. Treat. 1995; 26: 109–118
   Google Scholar
• Toi M., Taniguchi T., Yamamoto Y., Kurisaki T., Suzuki H., Tominaga T. Clinical Significance of the Determination of Angiogenic Factors. Eur. J. Cancer 1996; 32A: 2513–2519
   PubMed Web of Science ®Google Scholar
• Baselga J., Norton L., Masui H., Pandiella A., Coplan K., Wilson H. M., Jr., Mendelsohn J. Antitumor Effect of Doxorubicin in Combination with Anti-epidermal Growth Factor Receptor Monoclonal Antibodies. J. Nat. Cancer Inst. 1993; 85: 1327–1333
   PubMed Web of Science ®Google Scholar
• Hortobagyi G. N., Hung M. C., Buzdar A. V. Recent Developments in Breast Cancer Therapy. Sem. Oncol. 1999; 26: 11–20
   PubMed Web of Science ®Google Scholar
• Milas L., Mason K., Hunter N., Petersen S., Yamakawa M., Ang K., Mendelsohn J., Fan Z. In Vivo Enhancement of Tumor Radioresponse by C225 Antiepidermal Growth Factor Receptor Antibody (Abstract 4508). Proc. Am. Assoc. Cancer Res. 2000; 41: 709
   Google Scholar
• Folkman J., Langer R., Linhardt R., Haudenschild C., Taylor S. Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone. Science 1983; 221: 719–725
   PubMed Web of Science ®Google Scholar
• McLeskey S W, Ding I. Y.F., Lippman M. E., Karn F. G. MDA-MB-134 Breast Carcinoma Cells Overexpress Fibroblast Growth Factor (FGF) Receptors and Are Growth Inhibited by FGF Ligands. Cancer Res. 1994; 54: 523–530
   PubMed Web of Science ®Google Scholar
• Chandler L. A., Sosnowski B. A., Greenlen L., Aukerman S. L., Baird A., Pierce G. F. Prevalent Expression of Fibroblast Growth Factor (FGF) Receptors and FGF2 in Human Tumor Cell Lines. Int. J. Cancer 1999; 81: 451–458
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. Manual for Staging of Cancer. 4th Ed., J.B. Lippincott Corp., Philadelphia 1992
   Google Scholar
• Stanley K. E. Prognostic Factors for Survival in Patients with Inoperable Lung Cancer. J. Natl. Cancer Inst. 1980; 65: 25–32
   PubMed Web of Science ®Google Scholar
• Thomas K. A. Purification and Characterization of Acidic Fibroblast Growth Factor. Meth. Enzymol. 1987; 47: 120–135
   Google Scholar
• Starkey R. H., Orth D. N. Radioimmunoassay of Human Epidermal Growth Factor (Urogastrone). J. Clin. Endocrinol. Metab. 1977; 45(6)1144–1153
   PubMed Web of Science ®Google Scholar
• Underwood L. E., Murphy M. G. Radioimmunoassay of the Somatomedins/Insulinlike Growth Factors. Radioimmunoassay in Basic and Clinical Pharmacology, C. Patrano, B. A. Peskar. Springer Verlag, Berlin 1987; 561–574
   Google Scholar
• Baxter R. C., Martin J. L. Radioimmunoassay of Growth Hormone-Dependent Insulin Like Growth Factor Binding Protein in Human Plasma. J. Clin. Invest. 1986; 78: 1504–1512
   PubMed Web of Science ®Google Scholar
• Procedure Manual Tarrytown. Diagnostic Division. Miles, Inc., , NY
   Google Scholar
• Manz B., Alexander H., Wagner B., Pollow K. Twenty-four-hour Pattern of Serum Melatonin in Patients with Anorexia Nervosa Determined by Novel 125I-Radioimmunassay Without Extraction. Neuroendocrinology: New Frontiers, D. Gupta, H. A. Wollmann, M. B. Ranke. Brain Research Promotion, TübingenGermany 1990; 255–264
   Google Scholar
• Nelson W., Tong Y. L., Lee J. K., Halberg F. Methods for Cosinor Rhythmometry. Chronobiologia 1979; 6(4)305–323
   PubMedGoogle Scholar
• Haus E., Nicolau G. Y., Lakatua D., Sackett-Lundeen L. Reference Values for Chronopharmacology. Annu. Rev. Chronopharmacol. 1988; 4: 333–424
   Google Scholar
• Arendt J. The Pineal. Biological Rhythms in Clinical and Laboratory Medicine, Y. Touitou, E. Haus. Springer Verlag, New York 1994; 348–362
   Google Scholar
• Bartsch C., Bartsch H., Fuchs V., Lippert T. H., Bellman O., Gupta D. Stage Dependent Depression of Melatonin in Patients with Primary Breast Cancer. Cancer 1989; 64: 426–433
   PubMed Web of Science ®Google Scholar
• Follenius M., Brandenberger G., Hietter B. Diurnal Cortisol Peaks and Their Relationships to Meals. J. Clin. Endocrinol. Metab. 1982; 55: 757–761
   PubMed Web of Science ®Google Scholar
• Suteanu S., Haus E., Dumitriu L., Nicolau G. Y., Petrescu E., Berg H., Sackett-Lundeen L., Ionescu I., Reilly R. Circadian Rhythm of Pro- and Anti-inflammatory Factors in Patients with Rheumatoid Arthritis—226. Biol. Rhythm Res. 1995; 26(4)446
   Google Scholar
• Hirata Y., Moore G. W., Bertagua C., Orth D. N. Plasma Concentrations of Immunoreactive Human Epidermal Growth Factor (Urogastrone) in Man. J. Clin. Endocrinol. Metab. 1980; 50: 440–444
   PubMed Web of Science ®Google Scholar
• Ino M., Ushiro K., Ino C., Yamashita T., Kumazawa T. Kinetics of Epidermal Growth Factor in Saliva. Acta Otolaryngol. (Stockh.) 1993, suppl. 500: 126–130
   Google Scholar
• Salomon D. S., Brandt R., Ciardiello F., Normanno N. Epidermal Growth Factor Related Peptides and Their Receptors in Human Malignancies. Crit. Rev. Oncol. Hematol. 1995; 19: 183–232
   PubMed Web of Science ®Google Scholar
• Imagawa W., Yang J., Guzman R., Nandi S. Control of Mammary Gland Development. The Physiology of Reproduction, E. Knobil, J. D. Neill. Raven Press, Ltd., New York 1994; 1033–1063
   Google Scholar
• Normanno N., Ciardiello F., Brandt R., Salomon D. S. Epidermal Growth Factor Related Peptides in the Pathogenesis of Human Breast Cancer. Breast Cancer Res. Treat. 1994; 29(1)11–27
   PubMed Web of Science ®Google Scholar
• Merlo G. R., Basolo F., Fiore L., Duboc L., Hynes N. E. p53-Dependent and p53- Independent Activation of Apoptosis in Mammary Epithelial Cells Reveals a Survival Function of EGF and Insulin. J. Cell Biol. 1995; 128: 1185–1196
   PubMed Web of Science ®Google Scholar
• Armstrong D. K., Kaufmann S. H., Ottaviano Y. L., Furuya Y., Buckley J. A., Isaacs J. T., Davidson N. E. Epidermal Growth Factor-Mediated Apoptosis of MDA-MB-468 Human Breast Cancer Cells. Cancer Res. 1994; 54: 5280–5283
   PubMed Web of Science ®Google Scholar
• Chin Y. E., Kitagawa M., Kuida K., Flavell R. A., Fu X. Y. Activation of the STAT Signaling Pathway Can Cause Expression of Caspase 1 and Apoptosis. Mol. Cell Biol. 1997; 17: 5328–5337
   PubMed Web of Science ®Google Scholar
• Bolufar P., Linch A., Molina R., Alberola V., Vasquez C., Padilla J., Garcia-Conde J., Llopis F., Guillen V. Epidermal Growth Factor in Human Breast Cancer, Endometrial Carcinoma and Lung Cancer. Its Relation to Epidermal Growth Factor Receptor, Estradiol Receptor and Tumor TNM. Clin. Chim. Acta 1993; 215: 51–61
   PubMed Web of Science ®Google Scholar
• Damjanov I., Mildner B., Knowles B. B. Immunohistochemical Localization of the Epidermal Growth Factor Receptor in Normal Human Tissues. Lab. Invest. 1986; 55: 588–592
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y., Naber S. P., DeLellis R. A., Wolfe H. J., Marks P. J., McKenzie S. J., Yin S. Neu Oncogene Protein and Epidermal Growth Factor Receptor Are Independently Expressed in Benign and Malignant Breast Tissues. Hum. Pathol. 1990; 21: 750–758
   PubMed Web of Science ®Google Scholar
• Busam K. J., Tan L. K., Grauter S. R., Kohler S., Junkins-Hopkins J., Berwick M., Rosan P. P. Epidermal Growth Factor, Estrogen and Progesterone Receptor Expression in Primary Sweat Gland Carcinomas and Primary and Metastatic Mammary Carcinomas. Mod. Pathol. 1999; 12(8)786–793
   PubMed Web of Science ®Google Scholar
• Szepesházi K., Halmos G., Schally A. V., Arencibia J. M., Groot K., Vadillo-Buenfil M., Rodriguez-Martin E. Growth Inhibition of Experimental Pancreatic Cancers and Sustained Reduction in Epidermal Growth Factor Receptors During Therapy with Hormonal Peptide Analogues. J. Cancer Res. Clin. Oncol. 1999; 125: 444–452
   PubMed Web of Science ®Google Scholar
• O'Reilly T., Cozens R., Traxler P. In Vivo Anti-tumor Activity of the Epidermal Growth Factor Receptor (EGFR) Inhibitor. PKI 166 (Abstract 3069). Proc. Assoc. Cancer Res. 2000; 41: 481
   Google Scholar
• Schaller G., Bangemann N., Becker C., Buhler H., Opri F., Weitzel H. K. Therapy of Metastatic Breast Cancer with Humanized Antibodies Against the HER-2 Receptor Protein. J. Cancer Res. Clin. Oncol. 1999; 125(8–9)520–524
   PubMed Web of Science ®Google Scholar
• Weidner N., Semple J. P., Welch W. R., Folkman J. Tumor Angiogenesis and Metastasis—Correlation in Invasive Breast Carcinoma. N Engl. J. Med. 1991; 324: 1–8
   PubMed Web of Science ®Google Scholar
• Gonzalez A. M., Buscaglia M., Ong M., Baird A. Distribution of Basic Fibroblast Growth Factor in the 18 Day Rat Fetus: Localization in the Basement Membranes of Diverse Tissues. J. Cell Biol. 1990; 110: 753–765
   PubMed Web of Science ®Google Scholar
• Fujimoto K., Ichimori Y., Yamaguchi H., Arai K., Futami T., Ozono S., Hirao Y., Kakizoe T., Terada M., Okajima E. Basic Fibroblast Growth Factor as a Candidate Tumor Marker for Renal Cell Carcinoma. Jpn. J. Cancer Res. 1995; 86(2)182–186
   PubMedGoogle Scholar
• Kandel J., Bossy-Wetzel E., Radvanyi F., Klagsbrun M., Folkman J., Hanahan D. Neovascularization Is Associated with a Switch to the Export of bFGF in the Multistep Development of Fibrosarcoma. Cell 1991; 66: 1095–1104
   PubMed Web of Science ®Google Scholar
• Schulze-Osthoff K., Risau W., Vollmer E., Sorg C. In Situ Detection of Basic Fibroblast Growth Factor by Highly Specific Antibodies. Am. J. Pathol. 1990; 137: 85–92
   PubMed Web of Science ®Google Scholar
• Soutter A., Nguyen M., Watanabe H., Folkman J. Basic Fibroblast Growth Factor Secreted by an Animal Tumor Is Detectable in Urine. Cancer Res. 1993; 53: 5297–5299
   PubMed Web of Science ®Google Scholar
• Kornmann M., Beger H. G., Korc M. Role of Fibroblast Growth Factors and Their Receptors in Pancreatic Cancer and Chronic Pancreatitis. Pancreas 1998; 17(2)169–75
   PubMed Web of Science ®Google Scholar
• Rajaram S., Baylink D. J., Mohan S. Insulin-like Growth Factor Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions. Endocr. Rev. 1997; 18(6)801–831
   PubMed Web of Science ®Google Scholar
• Hwa V., Oh Y., Rosenfeld R. G. The Insulin Like Growth Factor-Binding Protein (IGFBP) Superfamily. Endocr. Rev. 1999; 20(6)761–787
   PubMed Web of Science ®Google Scholar
• Khandwala H. M., McCutcheon I. E., Flyvbjerg A., Friend K. E. The Effects of Insulin-like Growth Factors on Tumorigenesis and Neoplastic Growth. Endocr. Rev. 2000; 21(3)215–244
   PubMed Web of Science ®Google Scholar
• Hawkinson S. E., Willett W. C., Colditz G. A., Hunter D. J., Michaud D., Deroo B., Rosner B., Speizer F. E., Pollak M. Circulating Concentrations of Insulin-like Growth Factor-I and Risk of Breast Cancer. Lancet 1998; 351: 1393–1396
   PubMed Web of Science ®Google Scholar
• Bohlke K., Cramer D. W., Trichopoulos D., Mantzoros C. S. Insulin-like Growth Factor-I in Relation to Premenopausal Ductal Carcinoma In Situ of the Breast. Epidemiology 1999; 9: 570–573
   Web of Science ®Google Scholar
• Jones J. I., Clemmons D. R. Insulin-like Growth Factors at Their Binding Proteins: Biological Actions. Endocr. Rev. 1995; 16(1)3–34
   PubMed Web of Science ®Google Scholar
• Oh Y. IGF-Independent Regulation of Breast Cancer Growth by IGF Binding Proteins. Breast Cancer Res. Treat. 1998; 47: 283–293
   PubMed Web of Science ®Google Scholar
• Decensi A., Johansson H., Miceli R., Mariani L., Camerini T., Barreca A., Guerrieri-Gonzaga A., Costa A., Formelli F. Long Term Effects of Fenretinide on Circulating Levels of the IGF System in Premenopausal Women with Early Breast Cancer (Abstract). Proc. Am. Assoc. Cancer Res. 2000; 41: 141B
   Google Scholar
• Li B. D.L., Khosravi M. J., Berkel H. J., Diamandis A., Dayton M. A., Smith M., Yu H. Free Insulin-like Growth Factor-1 (IGF-1) and Breast Cancer Risk. Proc. Am. Assoc. Cancer Res. 2000; 41: 128
   Google Scholar
• Yu H., Shu O., Li B. D.L., Dia Q., Berkel H., Ji F., Zheng W. High Insulinlike Growth Factors (IGFS) and IGF Binding Protein-3 (IGFBP-3) Are Associated with Breast Cancer Risk in Chinese Women. Proc. Am. Assoc. Cancer Res. 2000; 41: 222
   Google Scholar
• Byrne C., Colditz G. A., Pollak M., Willett W. C., Speizer F. E., Hawkinson S. E. Plasma Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and Mammographic Density. Proc. Am. Assoc. Cancer Res. 2000; 41: 222
   Google Scholar
• Stratakis C. A., Mastorakos G., Magiakou M. A., Papavasiliou E. C., Panitsa-Faflia C., Georgiadis E., Batrinos M. L. Twenty-Four-Hour Secretion of Growth Hormone (GH) Insulin-like Growth Factors I and II, Prolactin (PRL) and Thyrotropin (TSH) in Young Adults of Normal and Tall Stature. Endocr. Res. 1996; 22(3)261–276
   PubMed Web of Science ®Google Scholar
• Heuck C., Skjaerbaek C., Orskov H., Wolthers O. D. Circadian Variation in Serum Free Ultrafiltrable Insulin-like Growth Factor I Concentrations in Healthy Children. Pediatr. Res. 1999; 45: 733–736
   PubMed Web of Science ®Google Scholar
• Jorgensen J. O.L., Blum W. F., Moller N., Ranke B. W., Christiansen J. Circadian Patterns of Insulin-like Growth Factor (IGF) II and IGF Binding Protein 3 in Growth Hormone Deficient Patients and Age and Sex Matched Normal Subjects. Acta Endocrinol. 1990; 123: 257–262
   PubMedGoogle Scholar
• Vermeulen A. Nyctohemeral Growth Hormone Profiles in Young and Aged Men: Correlation with Somatomedin-C Levels. J. Clin. Endocrinol. Metab. 1987; 64: 884–888
   PubMed Web of Science ®Google Scholar
• Baxter R. C., Cowell C. R. Diurnal Rhythm of Growth Hormone-Independent Binding Protein for Insulin-like Growth Factors in Human Plasma. J. Clin. Endocrinol. Metab. 1987; 65: 432–440
   PubMed Web of Science ®Google Scholar